search
Back to results

Effects of Combined Surgery on Obstructive Sleep Apnea in Obese Patients: an Open-label Randomized Controlled Clinical Trial

Primary Purpose

To Compare the Difference of AHI Variation Between LSG and Combined Surgery

Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Laparoscopic sleeve gastrectomy(LSG)
Uvulopalatopharyngoplasty(UPPP) and Adenoidectomy/Tonsillectomy
Sponsored by
Bing Wang
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for To Compare the Difference of AHI Variation Between LSG and Combined Surgery

Eligibility Criteria

16 Years - 65 Years (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Chinese Han population aged 16 to 65 years
  2. BMI more than 32.5Kg/㎡ with AHI more than ≥30/hour
  3. First diagnosed with PSG without any corresponding treatment;
  4. Adenoid tonsil hypertrophy (Friedman stage II-III).

Exclusion Criteria:

  1. Drug abuse, alcohol addiction and mental diseases
  2. Dysgnosia
  3. Over-high expectation
  4. Risk-averse patient;
  5. Poor tolerance to surgery
  6. Patient suffering from gastroesophageal reflux and hiatal hernia
  7. Central or mixed sleep apnea diagnosed by PSG
  8. PO2<60mmHg when the patient is awake
  9. Suffering from maligent tumor, neural system injury and respiratory insufficiency
  10. Hypothyroidism
  11. Other special issue decided by specialist.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    Active Comparator

    Arm Label

    Combined Surgery Group

    LSG Group

    Arm Description

    LSG + UPPP&Adenoidectomy/Tonsillectomy

    LSG only

    Outcomes

    Primary Outcome Measures

    The mean change in Apnoea-Hypopnoea Index (AHI)
    The mean change in AHI

    Secondary Outcome Measures

    Time to response
    AHI reduse to 50% of the base line
    Other PSG measures: average and lowest blood oxygen saturation at night
    in psg report
    Weight, BMI
    neck,chest,waist hip and biceps circumference
    Epworth Sleepiness Scale (ESS) scores
    Changes in the CT scan of upper airway and head radiography

    Full Information

    First Posted
    July 20, 2017
    Last Updated
    July 21, 2017
    Sponsor
    Bing Wang
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT03227939
    Brief Title
    Effects of Combined Surgery on Obstructive Sleep Apnea in Obese Patients: an Open-label Randomized Controlled Clinical Trial
    Official Title
    Effect of Laparoscopic Sleeve Gastrectomy (LSG) Plus Uvulopalatopharyngoplasty and Adenoidectomy/Tonsillectomy on Severe Obstructive Sleep Apnea & Hyponea Syndromes in Moderate-to-severe Obese Patients: an Open-label Randomized Controlled Clinical Trial
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    July 2017
    Overall Recruitment Status
    Unknown status
    Study Start Date
    July 25, 2017 (Anticipated)
    Primary Completion Date
    February 1, 2020 (Anticipated)
    Study Completion Date
    May 1, 2020 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor-Investigator
    Name of the Sponsor
    Bing Wang

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    This research is created for compare the difference of AHI variation between LSG and combined surgery on obstructive sleep apnea in obese patients , evaluate the risk of combined surgery and explore the correlative factor of the curative effect.
    Detailed Description
    Obesity is one of the new health challenges in China and all over the world,Morbidly obesity (MO) is an important risk factor for metabolic diseases and obstructive sleep apnea(OSA), which can be effectively and lastingly reduced by bariatric surgery. OSA is the most common type of sleep apnea and is caused by complete or partial obstructions of the upper airway. It is characterized by repetitive episodes of shallow or paused breathing during sleep, and is a potentially fatal disease. OSA has complex pathogenesis and numerous pathogeny, while morbidly obesity is one of the important risk factors of OSA. Previous research has shown that the incidence of OSA will rise by 1.14 % while body mass index(BMI) rise by 1%.Therefor, loseing weight is highly recommend for morbidly obese patients with OSA in clinical guideline for OSA both in USA and China, and bariatric surgery is effective for morbidly obese patients with OSA. Most yellow race morbidly obesity patients have abdominal obesity which is different from the white race,while Abdominal obesity is associated with greater incidence and more severely of OSA. There are maybe twenty million patients with OSA and 80% of them haven't been diagnosed. At present,. Laparoscopic sleeve gastrectomy(LSG) and laparoscopic Roux-en-Y gastric bypass(LRYGB) are two of the main bariatric surgical procedures performed in China. They can performed as one stage each or multiple sessions(LSG-LRYGB) which is depend on the severity of obesity and its complications. UPPP was first performed in 1981 by doctor Fujita and modified these years, it has been a standardized treatment for OSA. The effective rate of UPPP is less than 65% and is associated with the BMI and age of patients , younger and lower BMI means better effect. Consideration of the discontented outcome in obese patients, Simple UPPP is not recommended for OSA patients with morbidly obesity in clinical guidelines for OSA. Although simple LSG has a sure prostecdtive efficacy for both OSA and morbidly obesity, patients still need CPAP during several months after surgery. So we chosed patients who conformed the surgical indications of both morbidly obesity and OSA,and performed an combined surgery (LSG+UPPP+adenoidectomy/tonsillectomy). We found that combined surgery has a better short-term efficacy than simple LSG, so the randomized clinical trial(RCT) was designed to explore the efficacy of combined surgery in the treatment of severe OSA in moderate-to-severe obese patients.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    To Compare the Difference of AHI Variation Between LSG and Combined Surgery

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Masking
    None (Open Label)
    Allocation
    Randomized
    Enrollment
    100 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    Combined Surgery Group
    Arm Type
    Experimental
    Arm Description
    LSG + UPPP&Adenoidectomy/Tonsillectomy
    Arm Title
    LSG Group
    Arm Type
    Active Comparator
    Arm Description
    LSG only
    Intervention Type
    Procedure
    Intervention Name(s)
    Laparoscopic sleeve gastrectomy(LSG)
    Intervention Description
    LSG:All these operations were performed by the same surgeon team. Dissect the greater omentum alongside the greater gastric curvature, make sure that the greater gastric curvature and fundus of stomach were completely made free from pancreas and spleen.Fully Exposed left and right diaphragm angle and taking care not to injure the esophagus. Resection was started 2 to 4 cm from pylorus and alongside a 40Fr tube up to the esophagogastric junction and created a 60 to 80ml gastric lumen, removed the fundus of stomach thoroughly and take care of the esophagus and preventriculus. Repaired the hiatal hernia if it was exsit.
    Intervention Type
    Procedure
    Intervention Name(s)
    Uvulopalatopharyngoplasty(UPPP) and Adenoidectomy/Tonsillectomy
    Intervention Description
    UPPP:PPP is typically administered to patients with obstructive sleep apnea in isolation. It is administered as a stand-alone procedure in the hope that the tissue which obstructs the patient's airway is localized in the back of the throat. The rationale is that, by removing the tissue, the patient's airway will be wider and breathing will become easier.
    Primary Outcome Measure Information:
    Title
    The mean change in Apnoea-Hypopnoea Index (AHI)
    Description
    The mean change in AHI
    Time Frame
    At the 6 month after surgery
    Secondary Outcome Measure Information:
    Title
    Time to response
    Description
    AHI reduse to 50% of the base line
    Time Frame
    during 6 months after surgery
    Title
    Other PSG measures: average and lowest blood oxygen saturation at night
    Description
    in psg report
    Time Frame
    At the 6 month after surgery
    Title
    Weight, BMI
    Time Frame
    At the 6 month after surgery
    Title
    neck,chest,waist hip and biceps circumference
    Time Frame
    At the 6 month after surgery
    Title
    Epworth Sleepiness Scale (ESS) scores
    Time Frame
    At the 6 month after surgery
    Title
    Changes in the CT scan of upper airway and head radiography
    Time Frame
    At the 6 month after surgery

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    16 Years
    Maximum Age & Unit of Time
    65 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Chinese Han population aged 16 to 65 years BMI more than 32.5Kg/㎡ with AHI more than ≥30/hour First diagnosed with PSG without any corresponding treatment; Adenoid tonsil hypertrophy (Friedman stage II-III). Exclusion Criteria: Drug abuse, alcohol addiction and mental diseases Dysgnosia Over-high expectation Risk-averse patient; Poor tolerance to surgery Patient suffering from gastroesophageal reflux and hiatal hernia Central or mixed sleep apnea diagnosed by PSG PO2<60mmHg when the patient is awake Suffering from maligent tumor, neural system injury and respiratory insufficiency Hypothyroidism Other special issue decided by specialist.
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Bing Wang, M.D.
    Phone
    +86-15821423382
    Email
    wingping01@126.com

    12. IPD Sharing Statement

    Plan to Share IPD
    Undecided

    Learn more about this trial

    Effects of Combined Surgery on Obstructive Sleep Apnea in Obese Patients: an Open-label Randomized Controlled Clinical Trial

    We'll reach out to this number within 24 hrs